Follow‐up
acute respiratory illness, ARI
Following antiviral receipt, influenza‐positive participants were asked to return to the kiosk for symptom surveys and nasal swab collection 2–3 and 5–7 days after diagnosis (Figure (A) Study design overview including participant‐level study flow of the test‐and‐treat strategy from 11/15/19 to 4/30/21. (B) Total number of participants completing intervention study procedure steps based on eligibility screening. ARI, acute respiratory illness; RT‐PCT, reverse transcription polymerase chain reaction